Mckesson Medical-Surgical Inc. Corporate Office recalls Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton
Recalled June 15, 2022 · FDA recall D-1037-2022 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
cGMP deviations: Temperature abuse · FDA Class II
Units
1 box/50 blister packs per box
Sold at
USA nationwide.
Description
cGMP deviations: Temperature abuse
Product
Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx only, MFG: Avkare Inc., NDC 50268-523-15
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →